Carcinoma, nonsquamous non-small-cell lung

Clinical trials for Carcinoma, nonsquamous non-small-cell lung explained in plain language.

Never miss a new study

Get alerted when new Carcinoma, nonsquamous non-small-cell lung trials appear

Sign up with your email to follow new studies for Carcinoma, nonsquamous non-small-cell lung, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Completed 1

Lung cancer trial tests olaparib as maintenance therapy

Disease control Completed

This phase 3 trial tested whether adding the drug olaparib (Lynparza) to standard treatment with pembrolizumab (Keytruda) and chemotherapy helps people with advanced nonsquamous lung cancer live longer without their disease worsening. Over 1,000 participants received either olapa…

Matched conditions: CARCINOMA, NONSQUAMOUS NON-SMALL-CELL LUNG

Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control

Last updated Jul 08, 2026 00:00 UTC

Carcinoma, nonsquamous non-small-cell lung

Get alerted when new Carcinoma, nonsquamous non-small-cell lung trials appear

Lung cancer trial tests olaparib as maintenance therapy